DUX4 and facioscapulohumeral muscular dystrophy: For comparison, an alternative transgenic mouse model for chronic FSHD has recently been proposed; however, unlike in the human disease situation, the model uses constitutive tetracycline treatment to induce DUX4 at low levels in both muscle and non-muscle tissues of female mice (Bosnakovski et al., 2020).